Literature DB >> 1912981

Inotropic and electrophysiological effects of BDF 9148, a congener of DPI 201-106, in guinea-pig atria and papillary muscles.

H Brasch1, H Iven.   

Abstract

1. BDF 9148 is a newly synthesized congener of DPI 201-106 in which the piperazidinyl moiety has been replaced by an azetidine-3-oxy-moiety. The inotropic effect of both drugs was studied as well as their influence on the action potential, by use of standard microelectrode techniques. 2. BDF 9148 increased the contractile force of guinea-pig atria and papillary muscles. The EC50 was 1.32 X 10(-7) mol l-1 and 0.7 X 10(-6) mol l-1 respectively. DPI 201-106 was effective in a similar concentration-range, the EC50 being 2.6 X 10(-7) mol l-1 for atria and 2.8 X 10(-7) mol l-1 for papillary muscles. 3. Both drugs caused a concentration-dependent prolongation of the relaxation time of the isometric contraction curve. With 10(-6) mol l-1 BDF 9148, the mean increase was 39.1 +/- 4.4 ms in atria and 39.4 +/- 7.5 ms in papillary muscles while 10(-6) mol l-1 DPI 201-106 caused increases of 56.7 +/- 2.5 ms and 79.3 +/- 11.7 ms, respectively. The effect of BDF 9148 was not prevented by propranolol, but was reversed by 3 X 10(-6) mol l-1 tetrodotoxin. Pretreatment of atria with 3 X 10(-8) mol l-1 BDF shifted the concentration-response curve of ouabain to the left and reduced the EC50 of the glycoside from 3.21 X 10(-7) mol l-1 to 2 X 10(-7) mol l-1. 4. BDF 9148 and DPI 201-106 concentration-dependently increased the action potential duration of papillary muscles and their functional refractory period. The drugs did not modify the resting potential, the action potential amplitude or the maximum depolarization velocity.5. All effects of BDF 9148 persisted after washout. The lipophilic drug accumulated in the tissues and the tissue drug concentration was little reduced by washout of BDF 9148 from the organ bath.6. In contrast to DPI 201-106, which had a prominent negative chronotropic effect in right atria, BDF 9148 caused only a slight reduction of the beating frequency with the largest (3 x 10 5mol 11) concentration.7. The results are consistent with BDF 9148 being a sodium channel activator with much weaker influence on the beating frequency than the parent compound DPI 201-106.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912981      PMCID: PMC1908210          DOI: 10.1111/j.1476-5381.1991.tb12356.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Interaction of DPI 201-106 with cardiac glycosides.

Authors:  G Scholtysik; R Salzmann; W Gerber
Journal:  J Cardiovasc Pharmacol       Date:  1989-02       Impact factor: 3.105

2.  Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.

Authors:  M Böhm; F Diet; G Feiler; B Kemkes; E Kreuzer; C Weinhold; E Erdmann
Journal:  J Cardiovasc Pharmacol       Date:  1988-12       Impact factor: 3.105

3.  Clinical cardiac electrophysiologic evaluation of the positive inotropic agent, DPI 201-106.

Authors:  G S Butrous; N M Debbas; J Erwin; D W Davies; H P Keller; M W Lunnon; A W Nathan; A J Camm
Journal:  Eur Heart J       Date:  1988-05       Impact factor: 29.983

4.  Haemodynamic effects of DPI 201-106, following single intravenous dose administration to patients with moderate cardiac failure.

Authors:  J C Hogan; R A Greenbaum; M W Lunnon; A J Hilson; T R Evans
Journal:  Eur Heart J       Date:  1988-05       Impact factor: 29.983

5.  The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations.

Authors:  D Buggisch; G Isenberg; U Ravens; G Scholtysik
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

6.  Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.

Authors:  P K Siegl; M L Garcia; V F King; A L Scott; G Morgan; G J Kaczorowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

7.  Interaction of the cardiotonic agent DPI 201-106 with cardiac Ca2+ channels.

Authors:  M Holck; W Osterrieder
Journal:  J Cardiovasc Pharmacol       Date:  1988-04       Impact factor: 3.105

8.  DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.

Authors:  G Scholtysik; R Salzmann; R Berthold; J W Herzig; U Quast; R Markstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

9.  Removal of inactivation and blockade of cardiac Na+ channels by DPI 201-106: different voltage-dependencies of the drug actions.

Authors:  M Kohlhardt; U Fröbe; J W Herzig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

10.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.

Authors:  M D Feldman; L Copelas; J K Gwathmey; P Phillips; S E Warren; F J Schoen; W Grossman; J P Morgan
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

View more
  4 in total

1.  Effects of BDF 9198 on action potentials and ionic currents from guinea-pig isolated ventricular myocytes.

Authors:  K H Yuill; M K Convery; P C Dooley; S A Doggrell; J C Hancox
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.

Authors:  E J Kelso; B J McDermott; B Silke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

3.  Effective and steady differentiation of a clonal derivative of P19CL6 embryonal carcinoma cell line into beating cardiomyocytes.

Authors:  Itsuki Mueller; Ryosuke Kobayashi; Takayuki Nakajima; Maki Ishii; Kazushige Ogawa
Journal:  J Biomed Biotechnol       Date:  2010-03-28

4.  The inotropic agents DPI 201-106 and BDF 9148 differentially affect potassium currents of guinea-pig ventricular myocytes.

Authors:  G J Amos; U Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.